Morphea
☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Isilonda se Morphea sivela njenge patch ene-atrophic pigmented.
relevance score : -100.0%
ReferencesScleroderma sisifo esinqabileyo esichaphazela izicubu ezixhumeneyo, ezibonisa ulusu oluqinileyo kwaye ngamanye amaxesha luchaphazela amanye amalungu omzimba. Kukho iindidi ezimbini eziphambili: systemic sclerosis, ebandakanya ukuqina kwesikhumba kunye namalungu angaphakathi, kunye ne‑localized scleroderma, eyaziwa ngokuba yi‑morphea, ehlala ilinganiselwe eluswini nakwizicubu ezingaphantsi kwayo, kunye nekhosi enobungozi kunye nokuzibekela umda. Nangona i‑localized scleroderma ingaqhelekanga kwaye imbangela yayo ayicacanga, uphando lwakutsha lubonisa ukuba inokuchaphazela izitho zangaphakathi kwaye ikhokelele kwimicimbi eyahlukeneyo yezempilo. Unyango lwangoku lubalulekile ukunqanda iingxaki, xa kujongwa ubunzulu be‑localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, ekwabizwa ngokuba yi‑localized scleroderma, sisifo esinqabileyo sokuzikhusela komzimba esichaphazela izicubu ezixhumeneyo. Inokuvela ngeendlela ezahlukeneyo, kwaye ayiqhelekanga kakhulu, malunga ne‑0.4‑2.7 iimeko ngabantu aba‑100 000 ngonyaka ngamnye. Morphea idla ngokubonwa kubantwana abaphakathi kweminyaka eyi‑2 ukuya kwi‑14 ubudala, kwaye idla ngokuchaphazela amantombazana rhoqo kunamakhwenkwe.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
I‑Morphea sisifo esinqabileyo. Ngenxa yokwakheka kwefoto, i‑algorithm ingenza impazamo ekuxilongeni i‑Morphea.